Haemonetics Corp (HAE)
90.82
-0.96
(-1.05%)
USD |
NYSE |
Nov 14, 16:00
90.82
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Gross Profit (Annual): 691.55M for March 31, 2024
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
March 31, 2024 | 691.55M |
March 31, 2023 | 615.10M |
March 31, 2022 | 505.50M |
March 31, 2021 | 397.84M |
March 31, 2020 | 484.51M |
March 31, 2019 | 417.54M |
March 31, 2018 | 411.91M |
March 31, 2017 | 378.49M |
March 31, 2016 | 405.91M |
March 31, 2015 | 434.42M |
March 31, 2014 | 468.36M |
March 31, 2013 | 428.13M |
March 31, 2012 | 369.24M |
March 31, 2011 | 355.21M |
March 31, 2010 | 337.48M |
March 31, 2009 | 308.17M |
March 31, 2008 | 257.72M |
Date | Value |
---|---|
March 31, 2007 | 227.30M |
March 31, 2006 | 220.54M |
March 31, 2005 | 197.88M |
March 31, 2004 | 173.54M |
March 31, 2003 | 154.70M |
March 31, 2002 | 154.83M |
March 31, 2001 | 166.91M |
March 31, 2000 | 156.36M |
March 31, 1999 | 158.22M |
March 31, 1998 | 158.70M |
March 31, 1997 | 178.70M |
March 31, 1996 | 167.70M |
March 31, 1995 | 158.50M |
March 31, 1994 | 154.20M |
March 31, 1993 | 127.50M |
March 31, 1992 | 97.90M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
397.84M
Minimum
2021
691.55M
Maximum
2024
538.90M
Average
505.50M
Median
2022
Gross Profit (Annual) Benchmarks
Boston Scientific Corp | 9.895B |
Baxter International Inc | 4.975B |
Globus Medical Inc | 1.020B |
Becton Dickinson & Co | 9.153B |
Insulet Corp | 1.160B |